Cargando…
In Vitro 3D Modeling of Neurodegenerative Diseases
The study of neurodegenerative diseases (such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, or amyotrophic lateral sclerosis) is very complex due to the difficulty in investigating the cellular dynamics within nervous tissue. Despite numerous advances in the in vivo study of the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855033/ https://www.ncbi.nlm.nih.gov/pubmed/36671665 http://dx.doi.org/10.3390/bioengineering10010093 |
_version_ | 1784873278068752384 |
---|---|
author | Louit, Aurélie Galbraith, Todd Berthod, François |
author_facet | Louit, Aurélie Galbraith, Todd Berthod, François |
author_sort | Louit, Aurélie |
collection | PubMed |
description | The study of neurodegenerative diseases (such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, or amyotrophic lateral sclerosis) is very complex due to the difficulty in investigating the cellular dynamics within nervous tissue. Despite numerous advances in the in vivo study of these diseases, the use of in vitro analyses is proving to be a valuable tool to better understand the mechanisms implicated in these diseases. Although neural cells remain difficult to obtain from patient tissues, access to induced multipotent stem cell production now makes it possible to generate virtually all neural cells involved in these diseases (from neurons to glial cells). Many original 3D culture model approaches are currently being developed (using these different cell types together) to closely mimic degenerative nervous tissue environments. The aim of these approaches is to allow an interaction between glial cells and neurons, which reproduces pathophysiological reality by co-culturing them in structures that recapitulate embryonic development or facilitate axonal migration, local molecule exchange, and myelination (to name a few). This review details the advantages and disadvantages of techniques using scaffolds, spheroids, organoids, 3D bioprinting, microfluidic systems, and organ-on-a-chip strategies to model neurodegenerative diseases. |
format | Online Article Text |
id | pubmed-9855033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98550332023-01-21 In Vitro 3D Modeling of Neurodegenerative Diseases Louit, Aurélie Galbraith, Todd Berthod, François Bioengineering (Basel) Review The study of neurodegenerative diseases (such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, or amyotrophic lateral sclerosis) is very complex due to the difficulty in investigating the cellular dynamics within nervous tissue. Despite numerous advances in the in vivo study of these diseases, the use of in vitro analyses is proving to be a valuable tool to better understand the mechanisms implicated in these diseases. Although neural cells remain difficult to obtain from patient tissues, access to induced multipotent stem cell production now makes it possible to generate virtually all neural cells involved in these diseases (from neurons to glial cells). Many original 3D culture model approaches are currently being developed (using these different cell types together) to closely mimic degenerative nervous tissue environments. The aim of these approaches is to allow an interaction between glial cells and neurons, which reproduces pathophysiological reality by co-culturing them in structures that recapitulate embryonic development or facilitate axonal migration, local molecule exchange, and myelination (to name a few). This review details the advantages and disadvantages of techniques using scaffolds, spheroids, organoids, 3D bioprinting, microfluidic systems, and organ-on-a-chip strategies to model neurodegenerative diseases. MDPI 2023-01-10 /pmc/articles/PMC9855033/ /pubmed/36671665 http://dx.doi.org/10.3390/bioengineering10010093 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Louit, Aurélie Galbraith, Todd Berthod, François In Vitro 3D Modeling of Neurodegenerative Diseases |
title | In Vitro 3D Modeling of Neurodegenerative Diseases |
title_full | In Vitro 3D Modeling of Neurodegenerative Diseases |
title_fullStr | In Vitro 3D Modeling of Neurodegenerative Diseases |
title_full_unstemmed | In Vitro 3D Modeling of Neurodegenerative Diseases |
title_short | In Vitro 3D Modeling of Neurodegenerative Diseases |
title_sort | in vitro 3d modeling of neurodegenerative diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855033/ https://www.ncbi.nlm.nih.gov/pubmed/36671665 http://dx.doi.org/10.3390/bioengineering10010093 |
work_keys_str_mv | AT louitaurelie invitro3dmodelingofneurodegenerativediseases AT galbraithtodd invitro3dmodelingofneurodegenerativediseases AT berthodfrancois invitro3dmodelingofneurodegenerativediseases |